CytoSorbents Corp (CTSO)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$0.433

Buy

$0.4864

arrow-down$-0.029 (-5.94%)

Prices updated at 05 Jun 2026, 21:10 EDT
| Prices minimum 15 mins delay
|
Prices in USD

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous poly ...
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Michael G. Bator
CEO
Dr. Phillip P. Chan, M.D.,PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
129
Head office
305 College Road East
Princeton
United States
08540
mobile
+1 732 329-8885
letter
avogel@cytosorbents.com

Key personnel

Salary
Dr. Edward R. Jones, M.B.A.,M.D.
Independent Director
0.07m
Mr. Peter J. Mariani
Chief Financial Officer and Principal Accounting Officer
0.15m
Dr. Phillip P. Chan, M.D.,PhD
Chief Executive Officer and Director
0.36m
Mr. Alan D. Sobel, C.P.A.
Independent Director
0.09m
Mr. Michael G. Bator
Chairman of the Board
0.12m
Ms. Jiny Kim, M.B.A.
Independent Director
0.07m
Mr. Vincent J. Capponi, M.S.
President and Chief Operating Officer
0.38m
Dr. Efthymios Nikolaos Deliargyris, M.D.
Chief Medical Officer
0.36m

Top 5 shareholders

No. of shares
Avenir Corporation5,215,776
Vanguard Group Inc2,204,294
Vanguard Capital Management, LLC1,879,989
Skylands Capital, LLC1,707,498
Neuberger Berman Investment Advisers LLC1,683,007

Director dealings

Action
18 Nov 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
08 Aug 2025-
24 Feb 2025-
24 Feb 2025-
24 Feb 2025-
24 Feb 2025-
24 Feb 2025-
24 Feb 2025-
24 Feb 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.